Cargando…
An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity
Following the introduction of effective protein-polysaccharide conjugate vaccines against capsular group C meningococcal disease in Europe, meningococci of capsular group B remain a major cause of death and can result in debilitating sequelae. The outer membrane proteins PorA and FetA have previousl...
Autores principales: | Norheim, Gunnstein, Sanders, Holly, Mellesdal, Jardar W., Sundfør, Idunn, Chan, Hannah, Brehony, Carina, Vipond, Caroline, Dold, Chris, Care, Rory, Saleem, Muhammad, Maiden, Martin C. J., Derrick, Jeremy P., Feavers, Ian, Pollard, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577077/ https://www.ncbi.nlm.nih.gov/pubmed/26390123 http://dx.doi.org/10.1371/journal.pone.0134353 |
Ejemplares similares
-
FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression
por: Sanders, Holly, et al.
Publicado: (2015) -
A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
por: Marsay, L., et al.
Publicado: (2015) -
The effect of iron availability on transcription of the Neisseria
meningitidis fHbp gene varies among clonal complexes
por: Sanders, Holly, et al.
Publicado: (2012) -
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial
por: Rollier, Christine S., et al.
Publicado: (2022) -
Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
por: Sheerin, Dylan, et al.
Publicado: (2022)